Paige
About Paige
Paige is a pioneering healthcare AI company that has revolutionized cancer diagnostics and treatment through advanced computational pathology. Founded on the principle of leveraging artificial intelligence to address critical issues in oncology, Paige developed a cloud-based platform and AI applications designed to enhance pathologists’ workflow, increase diagnostic confidence, and improve patient outcomes globally. Their technology, built from an extensive dataset of digitized pathology slides, clinical reports, and genomic data, provides deep insights into the molecular and cellular complexities of cancer, enabling more precise detection, subtyping, grading, and biomarker identification across various cancer types, including prostate, breast, and gastrointestinal cancers.
Prior to its acquisition, Paige was recognized for its innovative AI-powered solutions, including the first FDA-cleared AI application in pathology. The company’s offerings, such as the Paige Prostate Suite, Paige Breast Suite, and Paige GI Suite, assist pathologists in identifying disease presence, assessing severity, and guiding treatment decisions. Paige also focused on developing foundation models and AI modules to accelerate research and development for novel computational pathology applications and to support pharmaceutical companies in biomarker discovery and personalized treatment evaluation.
In August 2025, Paige was acquired by Tempus AI, integrating its cutting-edge AI technology, extensive dataset of nearly 7 million digitized pathology slides, and foundational AI models into Tempus’s ecosystem to further advance cancer care.
Focus Areas
Business Intelligence
| Key Investors | Casdin Capital, Johnson & Johnson Innovation – JJDC, Inc., Goldman Sachs Asset Management, Healthcare Venture Partners, Breyer Capital, Julian Robertson, KKR, Catalio Capital Management, AI Venture Labs |
| Partnerships | Microsoft, Leica Biosystems, OptraSCAN, Hamamatsu, PathPresenter, Burjeel Holdings, Breast International Group (BIG), Lumea, Indica Labs, Aiforia, Quest Diagnostics, Philips |
| Acquisitions | Acquired by Tempus AI for $81.25M in August 2025 |
| Technology | Cloud-based platform, AI-powered solutions, deep learning algorithms, foundation models (Virchow, PRISM2), multi-modal AI models (combining vision and language), utilizes Microsoft Azure |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Paige's AI solutions offer significant advancements in cancer diagnostics. Expect improved diagnostic accuracy and efficiency, as AI applications assist in detecting subtle complexities of cancer, potentially reducing diagnostic errors and turnaround times. The AI acts as a 'second set of eyes,' allowing pathologists to focus on challenging cases and alleviate workload pressures. The ability to uncover molecular biomarkers directly from H&E slides facilitates more precise and personalized treatment planning. Furthermore, Paige's FDA-cleared solutions provide a high level of clinical validation and trust. The platform is designed to integrate seamlessly into existing digital pathology workflows, minimizing disruption and maximizing the benefits of AI-powered insights. The Paige Albau2122 co-pilot can further streamline your workflow with intuitive voice and text commands, enhancing the overall diagnostic process.
Paige's platform is built for interoperability, offering advanced integration capabilities. Its flexible architecture, powered by a set of APIs, allows for vendor-neutral integrations with diverse whole-slide image (WSI) scanners, Laboratory Information Systems (LIS), and both Paige's own AI solutions and third-party AI applications. This open approach ensures that labs and pathologists can connect their existing and future digital pathology applications into a single, managed environment, fostering customized workflows and avoiding vendor lock-in.
What the Web Says
Paige.ai operates in two distinct areas: AI-powered local SEO for businesses (often referred to as Paige by Merchynt) and AI-assisted diagnostics for cancer pathology (Paige AI). The local SEO tool is highly praised for its ease of use, automation, and effectiveness in improving Google Business Profile rankings and local search visibility. The healthcare-focused Paige AI is recognized as a solid medical tool, being the first company with FDA approval for AI-driven cancer diagnosis in pathology. Employer reviews for Paige (the healthcare AI company) indicate a positive work environment with strong leadership and good work-life balance.
Overall: PositiveStrengths
- Exceptional ease of use and intuitive features for local SEO.
- Strong automation capabilities for Google Business Profile management and reporting.
- Excellent and responsive customer support, including direct CEO involvement.
- Effective in improving Google Business Profile rankings and local SEO.
- FDA-approved AI for cancer diagnosis in pathology, improving detection rates.
- Positive employer ratings for work-life balance, leadership, and culture.
Limitations
- Editing limitations, such as inability to specify detailed requests for post rewrites.
- Challenging learning curve for some users, particularly with initial setup.
- Product can be considered pricey for some users ($99 per client).
- Desire for more guided tutorials for non-tech-savvy individuals.
- Video creation process can be clunky with script and image mismatches.
- Narrow focus on prostate cancer limits the addressable market for the healthcare AI.
Based on reviews from: G2, AI is Everywhere, Capterra, Wellfound, Elion, FeaturedCustomers, Reddit, Indeed.com, Built In NYC, AHRQ
Last updated: 2026-07-22
Videos
News, demos, and interviews about Paige.
Videos load interactively. If none appear, search YouTube for Paige →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]